Medacta Group S.A.
Medacta Group S.A. (MOVE.SW) Stock Overview
Explore Medacta Group S.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.8B
P/E Ratio
53.08
EPS (TTM)
$3.33
ROE
0.16%
MOVE.SW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Medacta Group S.A. (MOVE.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 53.08 and a market capitalization of 2.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Francesco Siccardi
1,907
Strada Regina, 34, Castel San Pietro
2019